Recent progress in the understanding of infective endocarditis

Area of Science:

• Cardiology
• Infectious Diseases
• Cardiac Surgery

Background:

• Infective endocarditis (IE) remains a significant cause of morbidity and mortality.
• Epidemiologic shifts, including increased healthcare-associated infections and Staphylococcus aureus predominance, complicate IE management.
• Recent guideline changes have reduced antibiotic prophylaxis due to unclear benefits, creating treatment uncertainties.

Purpose of the Study:

• To review current challenges and advancements in diagnosing and treating infective endocarditis.
• To evaluate the evolving role of antibiotic prophylaxis and diagnostic biomarkers.
• To assess the impact of surgical intervention timing and its outcomes in IE patients.

Main Methods:

• Literature review of recent epidemiologic trends, diagnostic advancements, and treatment strategies for infective endocarditis.
• Analysis of current guidelines regarding antibiotic prophylaxis.
• Evaluation of studies on surgical interventions and their timing in IE management.

Main Results:

• Staphylococcus aureus IE is associated with worse outcomes and less frequent surgical intervention.
• Early diagnosis and prognostic biomarkers show promise for improved patient outcomes.
• Surgery for complicated IE, including in cases of cerebral infarction, demonstrates low operative mortality and survival benefits.

Conclusions:

• Aggressive surgical consideration, even in complex or S. aureus IE cases, is recommended.
• Optimizing surgical timing during the active infection phase may improve outcomes.
• Further research is needed to define the optimal surgical strategy for all IE patient groups.